Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colorectal cancer (HIPECT4): final analysis of randomized clinical trial.

BJS open·2026
Same author

Correction: MORPHology and Inter-observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS: The MORPHEUS study.

Annals of surgical oncology·2026
Same author

MORPHology and Inter-observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS: The MORPHEUS study.

Annals of surgical oncology·2026
Same author

Role of cytoreductive surgery in the management of peritoneal metastases for gastrointestinal stromal tumors.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Benchmarking to validate the implementation of a robotic colorectal cancer surgery program. Proposal for a new method to createbenchmarks.

Journal of robotic surgery·2025
Same author

Education and Training in Peritoneal Surface Oncology.

Journal of surgical oncology·2024

Related Experiment Video

Updated: Jun 6, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Hyperthermic intraperitoneal chemotherapy: Rationale and technique.

Santiago González-Moreno1, Luis A González-Bayón, Gloria Ortega-Pérez

  • 1Santiago González-Moreno, Luis A González-Bayón, Gloria Ortega-Pérez, Peritoneal Surface Oncology Program, Department of Surgical Oncology, Centro Oncológico MD Anderson International España, 28033 Madrid, Spain.

World Journal of Gastrointestinal Oncology
|December 17, 2010
PubMed
Summary
This summary is machine-generated.

Complete cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) offers long-term survival for peritoneal neoplasms. HIPEC enhances chemotherapy

Keywords:
Cytoreductive surgeryHyperthermiaIntracavitary chemotherapyPeritoneal carcinomatosisPeritoneal neoplasms

More Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
07:47

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Related Experiment Videos

Last Updated: Jun 6, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
07:47

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Area of Science:

  • Surgical Oncology
  • Medical Oncology
  • Cancer Treatment

Background:

  • Peritoneal neoplasms, both primary and secondary, require advanced treatment strategies.
  • Complete cytoreductive surgery combined with perioperative intraperitoneal chemotherapy offers the only chance for long-term survival for select patients.
  • Hyperthermic intraperitoneal chemotherapy (HIPEC) is a common method of perioperative intraperitoneal chemotherapy administration.

Purpose of the Study:

  • To discuss the principles, administration, and considerations of hyperthermic intraperitoneal chemotherapy (HIPEC) in the context of cytoreductive surgery for peritoneal neoplasms.
  • To highlight the synergistic effects of hyperthermia and chemotherapy in cancer treatment.
  • To review current practices and future directions in HIPEC therapy.

Main Methods:

  • HIPEC involves delivering heated chemotherapy directly into the peritoneal cavity after cytoreductive surgery.
  • The procedure utilizes pharmacokinetic advantages of regional drug delivery and the direct cytotoxic effects of hyperthermia.
  • Chemotherapeutic agents with cell cycle nonspecific action and heat-synergistic effects are preferred.
  • Both open (Coliseum) and closed abdomen techniques are employed with comparable efficacy.

Main Results:

  • HIPEC enhances regional chemotherapy dose and improves drug penetration through hyperthermia.
  • Hyperthermia itself has a selective cell-killing effect on malignant cells.
  • The combination of surgery and HIPEC provides regional dose intensification for peritoneal neoplasms.

Conclusions:

  • HIPEC, combined with complete cytoreductive surgery, is a crucial treatment for selected patients with peritoneal neoplasms.
  • Careful patient selection, specialized training, and adherence to safety protocols are essential for HIPEC.
  • Ongoing research is needed to optimize HIPEC regimens and explore new drug combinations for improved outcomes.